Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy

European Journal of Echocardiography

Volumn 12, Issue 12, 2011, Pages 945-952

  Stoodley, Paul W ^a   Richards, David A B ^b,c   Hui, Rina ^d   Boyd, Anita ^c   Harnett, Paul R ^d   Meikle, Steven R ^a   Clarke, Jillian ^a   Thomas, Liza ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Anthracyclines; Left ventricular ejection fraction; Strain imaging

Indexed keywords

ANTHRACYCLINE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANALYSIS OF VARIANCE; ANTHRACYCLINES; FEMALE; HEART VENTRICLES; HUMANS; MIDDLE AGED; MYOCARDIUM; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84856326429     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jer187     Document Type: Article

References (26)

1. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:302-14.
2. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125:47-58.
3. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000;207:77-86.
4. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 2008;26:3777-84.
5. Bird BR, Swain SM. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res 2008;14:14-24. (Pubitemid 351377973)
6. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339:900-5. (Pubitemid 28446849)
7. Jurcut R, Wildiers H, Ganame J, D'Hooge J, De Backer J, Denys H et al. Strain rate imaging detects early cardiac effects of pegylated liposomal doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008;21: 1283-9.
8. McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003;146: 388-97. (Pubitemid 37083072)
9. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-5. (Pubitemid 39165138)
10. Otterstad JE. Measuring left ventricular volume and ejection fraction with the biplane Simpson's method. Heart 2002;88:559-60. (Pubitemid 35418061)
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108. (Pubitemid 43257193)
12. Marwick TH, Leano RL, Brown J, Sun J-P, Hoffmann R, Lysyansky P et al. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. J Am Coll Cardiol Imaging 2009;2:80-4.
13. Anderson RH, Ho SY, Redmann K, Sanchez-Quintana D, Lunkenheimer PP. The anatomical arrangement of the myocardial cells making up the ventricular mass. Eur J Cardiothorac Surg 2005;28:517-25. (Pubitemid 41348687)
14. Argyle RA, Ray SG. Stress and strain: double trouble or useful tool?. Eur J Echocardiogr 2009;10:716-22.
15. Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr 2004;17:36-44. (Pubitemid 38064113)
16. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 2003;108: 1299-301. (Pubitemid 37174405)
17. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1175-81.
18. Migrino RQ, Aggarwal D, Konorev E, Brahmbhatt T, Bright M, Kalyanaraman B. Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol 2008;34:208-14.
19. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011; 107:1375-80.
20. Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fossa A, Fossa SD et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. Am J Cardiol 2011;107:472-7.
21. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010;96:701-7.
22. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011;57:2263-70.
23. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-79. (Pubitemid 36605157)
24. Friedman MA, Bozdech MJ, Billingham ME, Rider AK. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. JAMA 1978;240: 1603-6. (Pubitemid 9047222)
25. Frei BLS, Scott A. A review of the cardiovascular effects of oncology agents. J Pharm Pract 2008;21:146-58.
26. Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 2010;55:213-20.